ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 580,03
-0,69%
Dow Jones
40 954,48
1,85%
DAX
18 518,03
-0,44%
Brent Oil
83,315
-1,22%
Bitcoin
64 559,77
-0,45%
Registration Strip Icon for default Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NYSE
  6. Teva Pharmaceutical Industries Ltd (TEVA)

  7. Teva Pharmaceutical Industries Ltd (TEVA) Actualités

TEVA

Teva Pharmaceutical Indu... (TEVA)

Teva Pharmaceutical Industries Ltd
De:
Trier par:
 Showing the most relevant articles for your search:NYSE:TEVA
DateHeureSourceTitreSymboleSociété
26/11/201919h18Dow Jones NewsFederal Prosecutors Launch Criminal Probe of Opioid Makers, DistributorsNYSE:TEVATeva Pharmaceutical Industries Ltd
25/11/201914h00Business WireTeva Announces Early Tender Results of its Debt Tender Offer and Election of Early SettlementNYSE:TEVATeva Pharmaceutical Industries Ltd
19/11/201919h21Business WireTeva Announces Successful Upsize of Senior Notes Offering and Pricing of $2.1 Billion of Senior NotesNYSE:TEVATeva Pharmaceutical Industries Ltd
16/11/201909h02Dow Jones NewsJohnson & Johnson Opioid Verdict Cut -- WSJNYSE:TEVATeva Pharmaceutical Industries Ltd
15/11/201923h15Dow Jones NewsJohnson & Johnson's Oklahoma Opioid Penalty Reduced to $465 MillionNYSE:TEVATeva Pharmaceutical Industries Ltd
08/11/201915h44Business WireTeva Announces $1.5 Billion Debt Tender OffersNYSE:TEVATeva Pharmaceutical Industries Ltd
08/11/201915h43Business WireTeva Announces Launch of $1,500,000,000 Offering of Senior NotesNYSE:TEVATeva Pharmaceutical Industries Ltd
07/11/201922h37Dow Jones NewsHigh Debt, Potential Litigation Costs Face New Teva CFONYSE:TEVATeva Pharmaceutical Industries Ltd
07/11/201913h15Business WireTeva & Celltrion Announce the Availability of TRUXIMA® (rituximab-abbs) Injection, the First Biosimilar to Rituxan® (rituxi...NYSE:TEVATeva Pharmaceutical Industries Ltd
07/11/201913h05Business WireTeva Announces Appointment of New Chief Financial OfficerNYSE:TEVATeva Pharmaceutical Industries Ltd
07/11/201913h00Business WireTeva Reports Third Quarter 2019 Financial ResultsNYSE:TEVATeva Pharmaceutical Industries Ltd
01/11/201923h00Business WireTeva to Host Conference Call to Discuss Third Quarter 2019 Financial Results at 8 a.m. ET on November 7, 2019 (Updated Dial-i...NYSE:TEVATeva Pharmaceutical Industries Ltd
31/10/201914h00PR Newswire (Canada)Teva Canada annonce le lancement des capsules [Pr]Teva-Fingolimod, une version générique bioéquivalente de [Pr]Gilenya®, ...NYSE:TEVATeva Pharmaceutical Industries Ltd
31/10/201913h54PR Newswire (Canada)Teva Canada Announces the Launch of a Bioequivalent Generic Version of [Pr]Gilenya®, [Pr]Teva-Fingolimod Capsules for the tr...NYSE:TEVATeva Pharmaceutical Industries Ltd
24/10/201914h00Business WireTeva to Present New Analyses of Fremanezumab and Country-Specific Burden of Migraine at 24th World Congress of NeurologyNYSE:TEVATeva Pharmaceutical Industries Ltd
22/10/201909h02Dow Jones NewsOpioid Deal Lifts Odds for Broader Accord -- WSJNYSE:TEVATeva Pharmaceutical Industries Ltd
21/10/201922h25Dow Jones NewsOpioid Deal Could Open Door to Bigger Settlement -- UpdateNYSE:TEVATeva Pharmaceutical Industries Ltd
21/10/201920h43Dow Jones NewsTeva to Donate Buprenorphine Naloxone Valued at About $23 Billion in Opioid-Related SettlementNYSE:TEVATeva Pharmaceutical Industries Ltd
21/10/201919h53Business WireTeva Settles Track 1 Opioid Cases and Reaches Agreement on Framework to Settle Remaining LitigationNYSE:TEVATeva Pharmaceutical Industries Ltd
21/10/201916h34Dow Jones NewsFour Drug Companies Reach Last-Minute Settlement in Opioid Litigation -- 3rd UpdateNYSE:TEVATeva Pharmaceutical Industries Ltd
21/10/201914h57Dow Jones NewsFour Drug Companies Reach Last-Minute Settlement in Opioid Litigation -- 2nd UpdateNYSE:TEVATeva Pharmaceutical Industries Ltd
21/10/201914h21Dow Jones NewsFour Drug Companies Reach Last-Minute Settlement in Opioid Litigation--UpdateNYSE:TEVATeva Pharmaceutical Industries Ltd
19/10/201904h48Dow Jones NewsMore Money Demanded in Opioid Settlement Talks -- UpdateNYSE:TEVATeva Pharmaceutical Industries Ltd
19/10/201901h57Dow Jones NewsMore Money Demanded in Opioid Settlement TalksNYSE:TEVATeva Pharmaceutical Industries Ltd
18/10/201909h02Dow Jones NewsBellwether Opioid Deal Talks Ramp Up -- WSJNYSE:TEVATeva Pharmaceutical Industries Ltd
18/10/201900h15Dow Jones NewsTalks to Settle Opioid Lawsuits IntensifyNYSE:TEVATeva Pharmaceutical Industries Ltd
07/10/201923h00Business WireTeva to Host Conference Call to Discuss Third Quarter 2019 Financial Results at 8 a.m. ET on November 7, 2019NYSE:TEVATeva Pharmaceutical Industries Ltd
02/10/201914h30Business WireTeva to Present New Data on AUSTEDO® (deutetrabenazine) Tablets at Psych Congress 2019NYSE:TEVATeva Pharmaceutical Industries Ltd
02/10/201914h00Business WireTeva Announces Leadership Change in its Global Operations GroupNYSE:TEVATeva Pharmaceutical Industries Ltd
30/09/201923h41Dow Jones NewsDrugmakers Look to Use Purdue Pharma's Bankruptcy to Settle Opioid SuitsNYSE:TEVATeva Pharmaceutical Industries Ltd
 Showing the most relevant articles for your search:NYSE:TEVA

Dernières Valeurs Consultées

TSXV
GBR
Great Bear Resources
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés